Clinical Trials in Salt Lake City

Showing 4401-4420 of 12,670 trials

Personalized Ultrasonic Brain Stimulation for Depression

NCT05301036

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will first be delivered using a range of stimulation parameters during psychological and physiological monitoring. A well-tolerated stimulation protocol will then be selected for subsequent testing in a blinded randomized sham-controlled cross-over trial to evaluate brain target engagement using magnetic resonance imaging.

Major Depressive Episode

University of Utah20 participantsStarted Jul 2022

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

NCT03425539

This study aimed to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease.

Fabry Disease

Idorsia Pharmaceuticals Ltd.118 participantsStarted Jun 2018

Birmingham, Alabama, United States • Irvine, California, United States • Oakland, California, United States +46 more locations

Personalized Ultrasonic Brain Stimulation for Depression

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Find Trials by Condition in Salt Lake City

Bioavailability and Food Effect Study of Cenobamate as an Oral Suspension and Tablet

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

Eptinezumab in Participants With Episodic Cluster Headache

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Advancing Symptom Alleviation With Palliative Treatment

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture

A Study of ZN-c5 in Subjects With Breast Cancer

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)